{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:15:26Z","timestamp":1783462526216,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100017557","name":"SNF | Swiss National Centre of Competence in Research Kidney Control of Homeostasis","doi-asserted-by":"publisher","award":["CRSII3_141814"],"award-info":[{"award-number":["CRSII3_141814"]}],"id":[{"id":"10.13039\/501100017557","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation Provisu"},{"name":"Foundation \"En souvenir du Dr Georges Borel\""},{"name":"Fondation Asiles des Aveugles"},{"DOI":"10.13039\/501100004784","name":"Novartis Stiftung f\u00fcr Medizinisch-Biologische Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004784","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    For 15 years, gene therapy has been viewed as a beacon of hope for inherited retinal diseases. Many preclinical investigations have centered around vectors with maximal gene expression capabilities, yet despite efficient gene transfer, minimal physiological improvements have been observed in various ciliopathies. Retinitis pigmentosa-type 28 (RP28) is the consequence of bi-allelic null mutations in the FAM161A, an essential protein for the structure of the photoreceptor connecting cilium (CC). In its absence, cilia become disorganized, leading to outer segment collapses and vision impairment. Within the human retina,\n                    <jats:italic>FAM161A<\/jats:italic>\n                    has two isoforms: the long one with exon 4, and the short one without it. To restore CC in\n                    <jats:italic>Fam161a<\/jats:italic>\n                    -deficient mice shortly after the onset of cilium disorganization, we compared AAV vectors with varying promoter activities, doses, and human isoforms. While all vectors improved cell survival, only the combination of both isoforms using the weak FCBR1-F0.4 promoter enabled precise FAM161A expression in the CC and enhanced retinal function. Our investigation into\n                    <jats:italic>FAM161A<\/jats:italic>\n                    gene replacement for RP28 emphasizes the importance of precise therapeutic gene regulation, appropriate vector dosing, and delivery of both isoforms. This precision is pivotal for secure gene therapy involving structural proteins like FAM161A.\n                  <\/jats:p>","DOI":"10.1038\/s44321-024-00053-x","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T07:02:05Z","timestamp":1710831725000},"page":"805-822","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Fine-tuning FAM161A gene augmentation therapy to restore retinal function"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6960-1291","authenticated-orcid":false,"given":"Yvan","family":"Arsenijevic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3501-6454","authenticated-orcid":false,"given":"Ning","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Mercey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younes","family":"El Fersioui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Koskiniemi-Kuendig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7605-5225","authenticated-orcid":false,"given":"Alexis-Pierre","family":"Bemelmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0733-9950","authenticated-orcid":false,"given":"Carlo","family":"Rivolta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Banin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dror","family":"Sharon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0363-1049","authenticated-orcid":false,"given":"Paul","family":"Guichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5092-2343","authenticated-orcid":false,"given":"Virginie","family":"Hamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1006-9733","authenticated-orcid":false,"given":"Corinne","family":"Kostic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,19]]},"reference":[{"key":"53_CR1","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.ymthe.2005.08.008","volume":"12","author":"GM Acland","year":"2005","unstructured":"Acland GM, Aguirre GD, Bennett J, Aleman TS, Cideciyan AV, Bennicelli J, Dejneka NS, Pearce-Kelling SE, Maguire AM, Palczewski K et al (2005) Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Mol Ther 12:1072\u20131082","journal-title":"Mol Ther"},{"key":"53_CR2","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1016\/j.ymthe.2021.03.021","volume":"29","author":"GD Aguirre","year":"2021","unstructured":"Aguirre GD, Cideciyan AV, Dufour VL, Ripolles-Garcia A, Sudharsan R, Swider M, Nikonov R, Iwabe S, Boye SL, Hauswirth WW et al (2021) Gene therapy reforms photoreceptor structure and restores vision in NPHP5-associated Leber congenital amaurosis. Mol Ther 29:2456\u20132468","journal-title":"Mol Ther"},{"key":"53_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1089\/hgtb.2011.034","volume":"23","author":"C Aurnhammer","year":"2012","unstructured":"Aurnhammer C, Haase M, Muether N, Hausl M, Rauschhuber C, Huber I, Nitschko H, Busch U, Sing A, Ehrhardt A et al (2012) Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences. Hum Gene Ther Methods 23:18\u201328","journal-title":"Hum Gene Ther Methods"},{"key":"53_CR4","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJMoa1414221","volume":"372","author":"JW Bainbridge","year":"2015","unstructured":"Bainbridge JW, Mehat MS, Sundaram V, Robbie SJ, Barker SE, Ripamonti C, Georgiadis A, Mowat FM, Beattie SG, Gardner PJ et al (2015) Long-term effect of gene therapy on Leber\u2019s congenital amaurosis. New Engl J Med 372:1887\u20131897","journal-title":"New Engl J Med"},{"key":"53_CR5","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ajhg.2010.07.022","volume":"87","author":"D Bandah-Rozenfeld","year":"2010","unstructured":"Bandah-Rozenfeld D, Mizrahi-Meissonnier L, Farhy C, Obolensky A, Chowers I, Pe\u2019er J, Merin S, Ben-Yosef T, Ashery-Padan R, Banin E et al (2010) Homozygosity mapping reveals null mutations in FAM161A as a cause of autosomal-recessive retinitis pigmentosa. Am J Hum Genet 87:382\u2013391","journal-title":"Am J Hum Genet"},{"key":"53_CR6","doi-asserted-by":"publisher","first-page":"e1000958","DOI":"10.1371\/journal.pgen.1000958","volume":"6","author":"GB Banks","year":"2010","unstructured":"Banks GB, Judge LM, Allen JM, Chamberlain JS (2010) The polyproline site in hinge 2 influences the functional capacity of truncated dystrophins. PLoS Genet 6:e1000958","journal-title":"PLoS Genet"},{"key":"53_CR7","doi-asserted-by":"publisher","first-page":"E5844","DOI":"10.1073\/pnas.1509914112","volume":"112","author":"WA Beltran","year":"2015","unstructured":"Beltran WA, Cideciyan AV, Iwabe S, Swider M, Kosyk MS, McDaid K, Martynyuk I, Ying GS, Shaffer J, Deng WT et al (2015) Successful arrest of photoreceptor and vision loss expands the therapeutic window of retinal gene therapy to later stages of disease. Proc Natl Acad Sci USA 112:E5844\u2013E5853","journal-title":"Proc Natl Acad Sci USA"},{"key":"53_CR8","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/mt.2015.11","volume":"23","author":"A Berger","year":"2015","unstructured":"Berger A, Lorain S, Josephine C, Desrosiers M, Peccate C, Voit T, Garcia L, Sahel JA, Bemelmans AP (2015) Repair of rhodopsin mRNA by spliceosome-mediated RNA trans-splicing: a new approach for autosomal dominant retinitis pigmentosa. Mol Ther 23:918\u2013930","journal-title":"Mol Ther"},{"key":"53_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72028-0","volume":"10","author":"A Beryozkin","year":"2020","unstructured":"Beryozkin A, Khateb S, Idrobo-Robalino CA, Khan MI, Cremers FPM, Obolensky A, Hanany M, Mezer E, Chowers I, Newman H et al (2020) Unique combination of clinical features in a large cohort of 100 patients with retinitis pigmentosa caused by FAM161A mutations. Sci Rep 10:15156","journal-title":"Sci Rep"},{"key":"53_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81414-1","volume":"11","author":"A Beryozkin","year":"2021","unstructured":"Beryozkin A, Matsevich C, Obolensky A, Kostic C, Arsenijevic Y, Wolfrum U, Banin E, Sharon D (2021) A new mouse model for retinal degeneration due to Fam161a deficiency. Sci Rep 11:2030","journal-title":"Sci Rep"},{"key":"53_CR11","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1126\/science.1240985","volume":"341","author":"S Bhogaraju","year":"2013","unstructured":"Bhogaraju S, Cajanek L, Fort C, Blisnick T, Weber K, Taschner M, Mizuno N, Lamla S, Bastin P, Nigg EA et al (2013) Molecular basis of tubulin transport within the cilium by IFT74 and IFT81. Science 341:1009\u2013112","journal-title":"Science"},{"key":"53_CR12","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1093\/hmg\/ddv085","volume":"24","author":"SA Di Gioia","year":"2015","unstructured":"Di Gioia SA, Farinelli P, Letteboer SJ, Arsenijevic Y, Sharon D, Roepman R, Rivolta C (2015) Interactome analysis reveals that FAM161A, deficient in recessive retinitis pigmentosa, is a component of the Golgi-centrosomal network. Hum Mol Genet 24:3359\u201371","journal-title":"Hum Mol Genet"},{"key":"53_CR13","doi-asserted-by":"publisher","first-page":"5174","DOI":"10.1093\/hmg\/dds368","volume":"21","author":"SA Di Gioia","year":"2012","unstructured":"Di Gioia SA, Letteboer SJ, Kostic C, Bandah-Rozenfeld D, Hetterschijt L, Sharon D, Arsenijevic Y, Roepman R, Rivolta C (2012) FAM161A, associated with retinitis pigmentosa, is a component of the cilia-basal body complex and interacts with proteins involved in ciliopathies. Hum Mol Genet 21:5174\u20135184","journal-title":"Hum Mol Genet"},{"key":"53_CR14","doi-asserted-by":"publisher","first-page":"e169162","DOI":"10.1172\/jci.insight.169162","volume":"8","author":"S Faber","year":"2023","unstructured":"Faber S, Mercey O, Junger K, Garanto A, May-Simera H, Ueffing M, Collin RW, Boldt K, Guichard P, Hamel V et al (2023) Gene augmentation of LCA5-associated Leber congenital amaurosis ameliorates bulge region defects of the photoreceptor ciliary axoneme. JCI Insight 8:e169162","journal-title":"JCI Insight"},{"key":"53_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41592-018-0238-1","volume":"16","author":"D Gambarotto","year":"2019","unstructured":"Gambarotto D, Zwettler FU, Le Guennec M, Schmidt-Cernohorska M, Fortun D, Borgers S, Heine J, Schloetel JG, Reuss M, Unser M et al (2019) Imaging cellular ultrastructures using expansion microscopy (U-ExM). Nat Methods 16:71\u201374","journal-title":"Nat Methods"},{"key":"53_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2019.100827","volume":"77","author":"AV Garafalo","year":"2020","unstructured":"Garafalo AV, Cideciyan AV, Heon E, Sheplock R, Pearson A, WeiYang Yu C, Sumaroka A, Aguirre GD, Jacobson SG (2020) Progress in treating inherited retinal diseases: early subretinal gene therapy clinical trials and candidates for future initiatives. Prog Retin Eye Res 77:100827","journal-title":"Prog Retin Eye Res"},{"key":"53_CR17","doi-asserted-by":"publisher","first-page":"e146511","DOI":"10.1172\/jci.insight.146511","volume":"6","author":"ZM Howard","year":"2021","unstructured":"Howard ZM, Dorn LE, Lowe J, Gertzen MD, Ciccone P, Rastogi N, Odom GL, Accornero F, Chamberlain JS, Rafael-Fortney JA (2021) Micro-dystrophin gene therapy prevents heart failure in an improved Duchenne muscular dystrophy cardiomyopathy mouse model. JCI Insight 6:e146511","journal-title":"JCI Insight"},{"key":"53_CR18","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.omtn.2022.12.007","volume":"31","author":"Y Hsu","year":"2023","unstructured":"Hsu Y, Bhattarai S, Thompson JM, Mahoney A, Thomas J, Mayer SK, Datta P, Garrison J, Searby CC, Vandenberghe LH et al (2023) Subretinal gene therapy delays vision loss in a Bardet-Biedl Syndrome type 10 mouse model. Mol Ther Nucleic Acids 31:164\u2013181","journal-title":"Mol Ther Nucleic Acids"},{"key":"53_CR19","doi-asserted-by":"publisher","first-page":"5197","DOI":"10.1093\/hmg\/ddu242","volume":"23","author":"M Karlstetter","year":"2014","unstructured":"Karlstetter M, Sorusch N, Caramoy A, Dannhausen K, Aslanidis A, Fauser S, Boesl MR, Nagel-Wolfrum K, Tamm ER, Jagle H et al (2014) Disruption of the retinitis pigmentosa 28 gene Fam161a in mice affects photoreceptor ciliary structure and leads to progressive retinal degeneration. Hum Mol Genet 23:5197\u20135210","journal-title":"Hum Mol Genet"},{"key":"53_CR20","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/sj.gt.3301948","volume":"10","author":"C Kostic","year":"2003","unstructured":"Kostic C, Chiodini F, Salmon P, Wiznerowicz M, Deglon N, Hornfeld D, Trono D, Aebischer P, Schorderet DF, Munier FL et al (2003) Activity analysis of housekeeping promoters using self-inactivating lentiviral vector delivery into the mouse retina. Gene Ther 10:818\u2013821","journal-title":"Gene Ther"},{"key":"53_CR21","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.ajhg.2010.07.018","volume":"87","author":"T Langmann","year":"2010","unstructured":"Langmann T, Di Gioia SA, Rau I, Stohr H, Maksimovic NS, Corbo JC, Renner AB, Zrenner E, Kumaramanickavel G, Karlstetter M et al (2010) Nonsense mutations in FAM161A cause RP28-associated recessive retinitis pigmentosa. Am J Hum Genet 87:376\u2013381","journal-title":"Am J Hum Genet"},{"key":"53_CR22","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.12688\/f1000research.25870.1","volume":"9","author":"TP Levine","year":"2020","unstructured":"Levine TP (2020) Structural bioinformatics predicts that the Retinitis Pigmentosa-28 protein of unknown function FAM161A is a homologue of the microtubule nucleation factor Tpx2. F1000Res 9:1052","journal-title":"F1000Res"},{"key":"53_CR37","doi-asserted-by":"crossref","unstructured":"Le Borgne PGL, Laporte MH, Lemullois M, Bouhouche K, Temagoult M, Rosnet O, Le Guennec M, Ligni\u00e8res L, Chevreux G, Koll F, Hamel V, Guichard P, Tassin AM (2022) The evolutionary conserved complex CEP90, FOPNL and OFD1 specifies the future location of centriolar distal appendages, and promotes their assembly. bioRxiv","DOI":"10.1101\/2021.07.13.452210"},{"key":"53_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz4137","volume":"6","author":"M Le Guennec","year":"2020","unstructured":"Le Guennec M, Klena N, Gambarotto D, Laporte MH, Tassin AM, van den Hoek H, Erdmann PS, Schaffer M, Kovacik L, Borgers S et al (2020) A helical inner scaffold provides a structural basis for centriole cohesion. Sci Adv 6:eaaz4137","journal-title":"Sci Adv"},{"key":"53_CR38","doi-asserted-by":"crossref","unstructured":"Lima WC, Cosson P (2019) The AJ514 antibody recognizes the common antigen 1 from Dictyostelium discoideum by immunofluorescence. Antibody Reports 2:e45","DOI":"10.24450\/journals\/abrep.2019.e45"},{"key":"53_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.trsl.2017.06.012","volume":"188","author":"A Matet","year":"2017","unstructured":"Matet A, Kostic C, Bemelmans AP, Moulin A, Rosolen SG, Martin S, Mavilio F, Amirjanians V, Stieger K, Lorenz B et al (2017) Evaluation of tolerance to lentiviral LV-RPE65 gene therapy vector after subretinal delivery in non-human primates. Transl Res 188:40\u201357.e4","journal-title":"Transl Res"},{"key":"53_CR25","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1016\/j.ymthe.2023.08.011","volume":"31","author":"C Matsevich","year":"2023","unstructured":"Matsevich C, Gopalakrishnan P, Chang N, Obolensky A, Beryozkin A, Salameh M, Kostic C, Sharon D, Arsenijevic Y, Banin E (2023) Gene augmentation therapy attenuates retinal degeneration in a knockout mouse model of Fam161a retinitis pigmentosa. Mol Ther 31:2948\u20132961","journal-title":"Mol Ther"},{"key":"53_CR26","doi-asserted-by":"publisher","first-page":"dev169474","DOI":"10.1242\/dev.169474","volume":"146","author":"CB Mellough","year":"2019","unstructured":"Mellough CB, Bauer R, Collin J, Dorgau B, Zerti D, Dolan DWP, Jones CM, Izuogu OG, Yu M, Hallam D et al (2019) An integrated transcriptional analysis of the developing human retina. Development 146:dev169474","journal-title":"Development"},{"key":"53_CR27","doi-asserted-by":"publisher","first-page":"e3001649","DOI":"10.1371\/journal.pbio.3001649","volume":"20","author":"O Mercey","year":"2022","unstructured":"Mercey O, Kostic C, Bertiaux E, Giroud A, Sadian Y, Gaboriau DCA, Morrison CG, Chang N, Arsenijevic Y, Guichard P et al (2022) The connecting cilium inner scaffold provides a structural foundation that protects against retinal degeneration. PLoS Biol 20:e3001649","journal-title":"PLoS Biol"},{"key":"53_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7006","volume":"6","author":"KM Nishiguchi","year":"2015","unstructured":"Nishiguchi KM, Carvalho LS, Rizzi M, Powell K, Holthaus SM, Azam SA, Duran Y, Ribeiro J, Luhmann UF, Bainbridge JW et al (2015) Gene therapy restores vision in rd1 mice after removal of a confounding mutation in Gpr179. Nat Commun 6:6006","journal-title":"Nat Commun"},{"key":"53_CR29","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1167\/iovs.05-0371","volume":"46","author":"BS Pawlyk","year":"2005","unstructured":"Pawlyk BS, Smith AJ, Buch PK, Adamian M, Hong DH, Sandberg MA, Ali RR, Li T (2005) Gene replacement therapy rescues photoreceptor degeneration in a murine model of Leber congenital amaurosis lacking RPGRIP. Invest Ophthalmol Vis Sci 46:3039\u20133045","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"53_CR30","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","volume":"390","author":"S Russell","year":"2017","unstructured":"Russell S, Bennett J, Wellman JA, Chung DC, Yu ZF, Tillman A, Wittes J, Pappas J, Elci O, McCague S et al (2017) Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet 390:849\u2013860","journal-title":"Lancet"},{"key":"53_CR31","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/sj.gt.3302698","volume":"13","author":"A Schambach","year":"2006","unstructured":"Schambach A, Bohne J, Baum C, Hermann FG, Egerer L, von Laer D, Giroglou T (2006) Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression. Gene Ther 13:641\u2013645","journal-title":"Gene Ther"},{"key":"53_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.101029","volume":"89","author":"N Schneider","year":"2022","unstructured":"Schneider N, Sundaresan Y, Gopalakrishnan P, Beryozkin A, Hanany M, Levanon EY, Banin E, Ben-Aroya S, Sharon D (2022) Inherited retinal diseases: Linking genes, disease-causing variants, and relevant therapeutic modalities. Prog Retin Eye Res 89:101029","journal-title":"Prog Retin Eye Res"},{"key":"53_CR33","doi-asserted-by":"publisher","first-page":"6118","DOI":"10.1167\/iovs.13-11673","volume":"54","author":"S Seo","year":"2013","unstructured":"Seo S, Mullins RF, Dumitrescu AV, Bhattarai S, Gratie D, Wang K, Stone EM, Sheffield V, Drack AV (2013) Subretinal gene therapy of mice with Bardet-Biedl syndrome type 1. Invest Ophthalmol Vis Sci 54:6118\u20136132","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"53_CR39","doi-asserted-by":"crossref","unstructured":"Tan E, Ding XQ, Saadi A, Agarwal N, Naash MI, Al-Ubaidi MR (2004) Expression of cone-photoreceptor-specific antigens in a cell line derived from retinal tumors in transgenic mice. Invest Ophthalmol Vis Sci 45:764\u2013768","DOI":"10.1167\/iovs.03-1114"},{"key":"53_CR34","doi-asserted-by":"publisher","first-page":"R108","DOI":"10.1093\/hmg\/ddz130","volume":"28","author":"I Trapani","year":"2019","unstructured":"Trapani I, Auricchio A (2019) Has retinal gene therapy come of age? From bench to bedside and back to bench. Hum Mol Genet 28:R108\u2013R118","journal-title":"Hum Mol Genet"},{"key":"53_CR35","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1093\/hmg\/dds268","volume":"21","author":"F Zach","year":"2012","unstructured":"Zach F, Grassmann F, Langmann T, Sorusch N, Wolfrum U, Stohr H (2012) The retinitis pigmentosa 28 protein FAM161A is a novel ciliary protein involved in intermolecular protein interaction and microtubule association. Hum Mol Genet 21:4573\u20134586","journal-title":"Hum Mol Genet"},{"key":"53_CR36","doi-asserted-by":"publisher","first-page":"e143285","DOI":"10.1172\/jci.insight.143285","volume":"6","author":"J Zhang","year":"2021","unstructured":"Zhang J, Hou Z, Wang X, Jiang H, Neng L, Zhang Y, Yu Q, Burwood G, Song J, Auer M et al (2021) VEGFA165 gene therapy ameliorates blood-labyrinth barrier breakdown and hearing loss. JCI Insight 6:e143285","journal-title":"JCI Insight"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-024-00053-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-024-00053-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-024-00053-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:47:36Z","timestamp":1779065256000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-024-00053-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4,15]]}},"alternative-id":["53"],"URL":"https:\/\/doi.org\/10.1038\/s44321-024-00053-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.10.06.561164","asserted-by":"object"}]},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,19]]},"assertion":[{"value":"10 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"YA, CK, NC, and DS are inventors of a patent pending \u201cGENE THERAPY FOR FAM161A-ASSOCIATED RETINOPATHIES AND OTHER CILIOPATHIES\u201d (PCT\/EP2023\/069304). Otherwise no other financial competing interests exist for this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}